Therapeutics for Duchenne muscular dystrophy: Current approaches and future directions

Journal of Molecular Medicine

Volumn 82, Issue 2, 2004, Pages 102-115

  Bogdanovich, Sasha ^a,b   Perkins, Kelly J ^a,c   Krag, Thomas O B ^a   Khurana, Tejvir S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Dystrophy; Mdx; Myostatin; Therapy; Utrophin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBODY; DILTIAZEM; DYSTROPHIN; GENTAMICIN; MYOSTATIN; MYOSTATIN ANTIBODY; NIFEDIPINE; SOMATOMEDIN C; STEROID; UNCLASSIFIED DRUG; UTROPHIN;

BECKER MUSCULAR DYSTROPHY; CALCIUM HOMEOSTASIS; CELL TRANSPLANTATION; DRUG MECHANISM; DUCHENNE MUSCULAR DYSTROPHY; GENE TARGETING; GENE THERAPY; MUSCLE WEAKNESS; MYOBLAST; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; STEM CELL TRANSPLANTATION;

CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; DRUG DESIGN; DYSTROPHIN; GENE EXPRESSION REGULATION; MEMBRANE PROTEINS; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, DUCHENNE; NEUREGULIN-1; PROMOTER REGIONS (GENETICS); UTROPHIN;

EID: 1542344795     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-003-0484-1     Document Type: Review

References (177)

1. Emery AEH (1993) Duchenne muscular dystrophy, 2nd edn. Oxford University Press, Oxford
2. Engel AG, Franzini-Armstrong C (1994) Myology. McGraw-Hill, New York
3. Duchenne GBA (1868) Recherches sur la paralysie musculaire pseudohypertrophique ou paralysie myo-sclerosique. Arch Gen Med 11:5-528
4. Dubowitz V (1975) Neuromuscular disorders in childhood. Old dogmas, new concepts. Arch Dis Child 50:335-346
5. Jennekens FG, ten Kate LP, de Visser M, Wintzen AR (1991) Diagnostic criteria for Duchenne and Becker muscular dystrophy and myotonic dystrophy. Neuromuscul Disord 1:389-391
6. Gowers W (1888) A manual of diseases of the nervous system. A & J Churchill, London
7. Kaminski HJ, al Hakim M, Leigh RJ, Katirji MB, Ruff RL (1992) Extraocular muscles are spared in advanced Duchenne dystrophy. Ann Neurol 32:586-588
8. Khurana TS, Prendergast RA, Alameddine HS, Tome FM, Fardeau M, Arahata K, Sugita H, Kunkel LM (1995) Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing. J Exp Med 182:467-475
9. Becker PE, Kiener F (1955) Eine neue X-chromosomale Muskeldystrophie. Arch Psychiatr Z Neurol 193:427
10. Kunkel LM et al. (1986) Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature 322:73-77
11. Monaco AP, Neve RL, Colletti-Feener C, Bertelson CJ, Kurnit DM, Kunkel LM (1986) Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323:646-650
12. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509-517
13. Hoffman EP, Brown RHJr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919-928
14. Monaco AP, Walker AP, Millwood I, Larin Z, Lehrach H (1992) A yeast artificial chromosome contig containing the complete Duchenne muscular dystrophy gene. Genomics 12:465-473
15. Coffey AJ, Roberts RG, Green ED, Cole CG, Butler R, Anand R, Giannelli F, Bentley DR (1992) Construction of a 2.6-Mb contig in yeast artificial chromosomes spanning the human dystrophin gene using an STS-based approach. Genomics 12:474-484
16. Koenig M, Monaco AP, Kunkel LM (1988) The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53:219-226
17. Roberts RG, Coffey AJ, Bobrow M, Bentley DR (1993) Exon structure of the human dystrophin gene. Genomics 16:536-538
18. Chamberlain JS, Pearlman JA, Muzny DM, Gibbs RA, Ranier JE, Caskey CT, Reeves AA (1988) Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. Science 239:1416-1418
19. Nudel U, Robzyk K, Yaffe D (1988) Expression of the putative Duchenne muscular dystrophy gene in differentiated myogenic cell cultures and in the brain. Nature 331:635-638
20. Watkins SC, Hoffman EP, Slayter HS, Kunkel LM (1988) Immunoelectron microscopic localization of dystrophin in myofibres. Nature 333:863-866
21. Arahata K, Ishiura S, Ishiguro T, Tsukahara T, Suhara Y, Eguchi C, Ishihara T, Nonaka I, Ozawa E, Sugita H (1988) Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature 333:861-863
22. Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Burghes AH, Belfall B, Klamut HJ, Talbot J, Hodges RS, Ray PN, Worton RG (1988) The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 333:466-469
23. Samitt CE, Bonilla E (1990) Immunocytochemical study of dystrophin at the myotendinous junction. Muscle Nerve 13:493-500
24. Byers TJ, Kunkel LM, Watkins SC (1991) The subcellular distribution of dystrophin in mouse skeletal, cardiac, and smooth muscle. J Cell Biol 115:411-421
25. Sealock R, Butler MH, Kramarcy NR, Gao KX, Murnane AA, Douville K, Froehner SC (1991) Localization of dystrophin relative to acetylcholine receptor domains in electric tissue and adult and cultured skeletal muscle. J Cell Biol 113:1133-1144
26. Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM (1988) An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2:90-95
27. Passos-Bueno MR, Vainzof M, Marie SK, Zatz M (1994) Half the dystrophin gene is apparently enough for a mild clinical course: confirmation of its potential use for gene therapy. Hum Mol Genet 3:919-922
28. England SB, Nicholson LV, Johnson MA, Forrest SM, Love DR, Zubrzycka-Gaarn EE, Bulman DE, Harris JB, Davies KE (1990) Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 343:180-182
29. Dunckley MG, Wells DJ, Walsh FS, Dickson G (1993) Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum Mol Genet 2:717-723
30. Ragot T, Vincent N, Chafey P, Vigne E, Gilgenkrantz H, Couton D, Cartaud J, Briand P, Kaplan JC, Perricaudet M (1993) Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361:647-650
31. Vainzof M, Passos-Bueno MR, Takata RI, Pavanello RC, Zatz M (1993) Intrafamilial variability in dystrophin abundance correlated with difference in the severity of the phenotype. J Neurol Sci 119:38-42
32. Kerr TP, Sewry CA, Robb SA, Roberts RG (2001) Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay? Hum Genet 109:402-407
33. Davison MD, Critchley DR (1988) alpha-Actinins and the DMD protein contain spectrin-like repeats. Cell 52:159-160
34. Winder SJ, Gibson TJ, Kendrick-Jones J (1995) Dystrophin and utrophin: the missing links! FEBS Lett 369:27-33
35. Koenig M, Kunkel LM (1990) Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J Biol Chem 265:4560-4566
36. Einbond A, Sudol M (1996) Towards prediction of cognate complexes between the WW domain and proline-rich ligands. FEBS Lett 384:1-8
37. Ponting CP, Blake DJ, Davies KE, Kendrick-Jones J, Winder SJ (1996) ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins. Trends Biochem Sci 21:11-13
38. Wrogemann K, Pena SD (1976) Mitochondrial calcium overload: a general mechanism for cell-necrosis in muscle diseases. Lancet I:672-674
39. Matsumura K, Campbell KP (1994) Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 17:2-15
40. Campbell KP (1995) Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80:675-679
41. Durbeej M, Campbell KP (2002) Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev 12:349-361
42. Straub V, Campbell KP (1997) Muscular dystrophies and the dystrophin-glycoprotein complex. Curr Opin Neurol 10:168-175
43. Nishino I, Ozawa E (2002) Muscular dystrophies. Curr Opin Neurol 15:539-544
44. Ozawa E, Yoshida M, Suzuki A, Mizuno Y, Hagiwara Y, Noguchi S (1995) Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet 4:1711-1716
45. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355:696-702
46. Suzuki A, Yoshida M, Yamamoto H, Ozawa E (1992) Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain. FEBS Lett 308:154-160
47. Suzuki A, Yoshida M, Hayashi K, Mizuno Y, Hagiwara Y, Ozawa E (1994) Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. Eur J Biochem 220:283-292
48. Ervasti JM, Campbell KP (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122:809-823
49. Matsumura K, Burghes AH, Mora M, Tome FM, Morandi L, Cornello F, Leturcq F, Jeanpierre M, Kaplan JC, Reinert P (1994) Immunohistochemical analysis of dystrophin-associated proteins in Becker/Duchenne muscular dystrophy with huge in-frame deletions in the NH2-terminal and rod domains of dystrophin. J Clin Invest 93:99-105
50. Love DR, Hill DF, Dickson G, Spurr NK, Byth BC, Marsden RF, Walsh FS, Edwards YH, Davies KE (1989) An autosomal transcript in skeletal muscle with homology to dystrophin. Nature 339:55-58
51. Khurana TS, Hoffman EP, Kunkel LM (1990) Identification of a chromosome 6-encoded dystrophin-related protein. J Biol Chem 265:16717-16720
52. Tinsley JM, Blake DJ, Roche A, Fairbrother U, Riss J, Byth BC, Knight AE, Kendrick-Jones J, Suthers GK, Love DR (1992) Primary structure of dystrophin-related protein. Nature 360:591-593
53. Roberts RG, Freeman TC, Kendall E, Vetrie DL, Dixon AK, Shaw-Smith C, Bone Q, Bobrow M (1996) Characterization of DRP2, a novel human dystrophin homologue. Nat Genet 13:223-226
54. Khurana TS, Engle EC, Bennett RR, Silverman GA, Selig S, Bruns GA, Kunkel LM (1994) (CA) repeat polymorphism in the chromosome 18 encoded dystrophin-like protein. Hum Mol Genet 3:841
55. Sadoulet-Puccio HM, Khurana TS, Cohen JB, Kunkel LM (1996) Cloning and characterization of the human homologue of a dystrophin related phosphoprotein found at the Torpedo electric organ post-synaptic membrane. Hum Mol Genet 5:489-496
56. Blake DJ, Nawrotzki R, Peters MF, Froehner SC, Davies KE (1996) Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein. J Biol Chem 271:7802-7810
57. Roberts RG, Bobrow M (1998) Dystrophins in vertebrates and invertebrates. Hum Mol Genet 7:589-595
58. Hoffman EP, Beggs AH, Koenig M, Kunkel LM, Angelini C (1989) Cross-reactive protein in Duchenne muscle. Lancet II:1211-1212
59. Fardeau M, Tome FM, Collin H, Augier N, Pons F, Leger J, Leger J (1990) Presence of dystrophine-like protein at the neuromuscular junction in Duchenne muscular dystrophy and in "mdx" mutant mice. C R Acad Sci III 311:197-204
60. Khurana TS, Watkins SC, Chafey P, Chelly J, Tome FM, Fardeau M, Kaplan JC, Kunkel LM (1991) Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul Disord 1:185-194
61. Nguyen TM, Ellis JM, Love DR, Davies KE, Gatter KC, Dickson G, Morris GE (1991) Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J Cell Biol 115:1695-1700
62. Ohlendieck K, Ervasti JM, Matsumura K, Kahl SD, Leveille CJ, Campbell KP (1991) Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron 7:499-508
63. Khurana TS, Watkins SC, Kunkel LM (1992) The subcellular distribution of chromosome 6-encoded dystrophin-related protein in the brain. J Cell Biol 119:357-366
64. Winder SJ, Kendrick-Jones J (1995) Calcium/calmodulin-dependent regulation of the NH2-terminal F-actin binding domain of utrophin. FEBS Lett 357:125-128
65. Morris GE, Nguyen TM, Nguyen TN, Pereboev A, Kendrick-Jones J, Winder SJ (1999) Disruption of the utrophin-actin interaction by monoclonal antibodies and prediction of an actin-binding surface of utrophin. Biochem J 337:119-123
66. Pearce M, Blake DJ, Tinsley JM, Byth BC, Campbell L, Monaco AP, Davies KE (1993) The utrophin and dystrophin genes share similarities in genomic structure. Hum Mol Genet 2:1765-1772
67. James M, Simmons C, Wise CJ, Jones GE, Morris GE (1995) Evidence for a utrophin-glycoprotein complex in cultured cell lines and a possible role in cell adhesion. Biochem Soc Trans 23:398S
68. Matsumura K, Ervasti JM, Ohlendieck K, Kahl SD, Campbell KP (1992) Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 360:588-591
69. Tommasi d, V, Di Zenzo G, Sudol M, Cesareni G, Dente L (2000) Contribution of the different modules in the utrophin carboxy-terminal region to the formation and regulation of the DAP complex. FEBS Lett 471:229-234
70. Peters MF, Sadoulet-Puccio HM, Grady MR, Kramarcy NR, Kunkel LM, Sanes JR, Sealock R, Froehner SC (1998) Differential membrane localization and intermolecular associations of alpha-dystrobrevin isoforms in skeletal muscle. J Cell Biol 142:1269-1278
71. Kramarcy NR, Vidal A, Froehner SC, Sealock R (1994) Association of utrophin and multiple dystrophin short forms with the mammalian M (r) 58:000 dystrophin-associated protein (syntrophin). J Biol Chem 269:2870-2876
72. Peters MF, O'Brien KF, Sadoulet-Puccio HM, Kunkel LM, Adams ME, Froehner SC (1997) Beta-dystrobrevin, a new member of the dystrophin family. Identification, cloning, and protein associations. J Biol Chem 272:31561-31569
73. Loh NY, Newey SE, Davies KE, Blake DJ (2000) Assembly of multiple dystrobrevin-containing complexes in the kidney. J Cell Sci 113:2715-2724
74. Olivieri NF, Weatherall DJ (1998) The therapeutic reactivation of fetal haemoglobin. Hum Mol Genet 7:1655-1658
75. Tinsley JM, Potter AC, Phelps SR, Fisher R, Trickett JI, Davies KE (1996) Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384:349-353
76. Gilbert R, Nalbantoglu J, Petrof BJ, Ebihara S, Guibinga GH, Tinsley JM, Kamen A, Massie B, Davies KE, Karpati G (1999) Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles. Hum Gene Ther 10:1299-1310
77. Allamand V, Campbell KP (2000) Animal models for muscular dystrophy: valuable tools for the development of therapies. Hum Mol Genet 9:2459-2467
78. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT, Kelly AM (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352:536-539
79. Sacco P, Jones DA, Dick JR, Vrbova G (1992) Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle. Clin Sci (Colch) 82:227-236
80. Moens P, Baatsen PH, Marechal G (1993) Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J Muscle Res Cell Motil 14:446-451
81. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90:3710-3714
82. Carpenter JL, Hoffman EP, Romanul FC, Kunkel LM, Rosales RK, Ma NS, Dasbach JJ, Rae JF, Moore FM, McAfee MB (1989) Feline muscular dystrophy with dystrophin deficiency. Am J Pathol 135:909-919
83. Cooper BJ, Winand NJ, Stedman H, Valentine BA, Hoffman EP, Kunkel LM, Scott MO, Fischbeck KH, Kornegay JN, Avery RJ (1988) The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 334:154-156
84. Schatzberg SJ, Olby NJ, Breen M, Anderson LV, Langford CF, Dickens HF, Wilton SD, Zeiss CJ, Binns MM, Kornegay JN, Morris GE, Sharp NJ (1999) Molecular analysis of a spontaneous dystrophin 'knockout' dog. Neuromuscul Disord 9:289-295
85. Gillis JM, Deconinck N (1998) The physiological evaluation of gene therapies of dystrophin-deficient muscles. Adv Exp Med Biol 453:411-416
86. Krag TO, Gyrd-Hansen M, Khurana TS (2001) Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy. Acta Physiol Scand 171:349-358
87. Khurana TS, Davies KE (2003) Pharmacological strategies for muscular dystrophy. Nat Rev Drug Discov 2:379-390
88. Gillis JM (2002) Multivariate evaluation of the functional recovery obtained by the overexpression of utrophin in skeletal muscles of the mdx mouse. Neuromuscul Disord 12 [Suppl 1]:S90-S94
89. Chen YW, Zhao P, Borup R, Hoffman EP (2000) Expression profiling in the muscular dystrophies: identification of novel aspects of molecular patophysiology. J Cell Biol 151:1321-1336
90. Rouger K, Le Cuniff M, Steenman M, Potier MC, Gibelin N, Dechesne CA, Leger JJ (2002) Global/temporal gene expression in diaphragm and hindlimb muscles of dystrophin-deficient (mdx) mice. Am J Physiol Cell Physiol 288:C773-C784
91. Bakay M, Zhao P, Chen J, Hoffman EP (2002) A web-accessible complete transcriptome of normal human and DMD muscle. Neuromuscul Disord 12:S125-S141
92. Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, Beggs AH, Kunkel LM (2002) Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal sceletal muscle. Proc Natl Acad Sci USA 99:15000-15005
93. Noguchi S, Tsukahara T, Fujita M, Kurokawa R, Tachikawa M, Toda T, Tsujimoto A, Arahata K, Nishino I (2003) cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Hum Mol Genet 12:595-600
94. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM (1989) Conversion of mdx myofibres from dystrophin-negative to positive by injection of normal myoblasts. Nature 337:176-179
95. Gussoni E, Pavlath GK, Lanctot AM, Sharma KR, Miller RG, Steinman L, Blau HM (1992) Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 356:435-438
96. Miller RG, Sharma KR, Pavlath GK, Gussoni E, Mynhier M, Lanctot AM, Greco CM, Steinman L, Blau HM (1997) Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study. Muscle Nerve 20:469-478
97. Neumeyer AM, Cros D, McKenna-Yasek D, Zawadzka A, Hoffman EP, Pegoraro E, Hunter RG, Munsat TL, Brown RH Jr (1998) Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy. Neurology 51:589-592
98. Tremblay JP, Malouin F, Roy R, Huard J, Bouchard JP, Satoh A, Richards CL (1993) Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 2:99-112
99. Mendell JR, Sahenk Z, Prior TW (1995) The childhood muscular dystrophies: diseases sharing a common pathogenesis of membrane instability. J Child Neurol 10:150-159
100. Ohtsuka Y, Udaka K, Yamashiro Y, Yagita H, Okumura K (1998) Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy. J Immunol 160:4635-4640
101. Gussoni E, Blau HM, Kunkel LM (1997) The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 3:970-977
102. Jankowski RJ, Deasy BM, Cao B, Gates C, Huard J (2002) The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells. J Cell Sci 115:4361-4374
103. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530
104. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM, Mulligan RC (1999) Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401:390-394
105. Bittner RE, Schofer C, Weipoltshammer K, Ivanova S, Streubel B, Hauser E, Freilinger M, Hoger H, Elbe-Burger A, Wachtler F (1999) Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl) 199:391-396
106. Gussoni E, Bennett RR, Muskiewicz KR, Meyerrose T, Nolta JA, Gilgoff I, Stein J, Chan YM, Lidov HG, Bonnemann CG, Von Moers A, Morris GE, Den Dunnen JT, Chamberlain JS, Kunkel LM, Weinberg K (2002) Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest 110:807-814
107. Cossu G, Mavilio F (2000) Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? J Clin Invest 105:1669-1674
108. Tinsley JM, Potter AC, Phelps SR, Fisher R, Trickett JI, Davies KE (1996) Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384:349-353
109. Wells D, Wells K (2002) Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD? Neuromuscul Disord 12 [Suppl]:S11
110. Wang B, Li J, Xiao X (2000) Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc Natl Acad Sci USA 97:13714-13719
111. Harper SQ, Hauser MA, DelloRusso C, Duan D, Crawford RW, Phelps SF, Harper HA, Robinson AS, Engelhardt JF, Brooks SV, Chamberlain JS (2002) Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat Med 8:253-261
112. Ebihara S, Guibinga GH, Gilbert R, Nalbantoglu J, Massie B, Karpati G, Petrof BJ (2000) Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice. Physiol Genomics 3:133-144
113. Wolff JA, Dowty ME, Jiao S, Repetto G, Berg RK, Ludtke JJ, Williams P, Slautterback DB (1992) Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle. J Cell Sci 103:1249-1259
114. Danko I, Williams P, Herweijer H, Zhang G, Latendresse JS, Bock I, Wolff JA (1997) High expression of naked plasmid DNA in muscles of young rodents. Hum Mol Genet 6:1435-1443
115. Acsadi G, Dickson G, Love DR, Jani A, Walsh FS, Gurusinghe A, Wolff JA, Davies KE (1991) Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 352:815-818
116. Thioudellet C, Blot S, Squiban P, Fardeau M, Braun S (2002) Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. I. Rationale. Neuromuscul Disord 12 [Suppl 1]:S49-S51
117. Romero NB, Benveniste O, Payan C, Braun S, Squiban P, Herson S, Fardeau M (2002) Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies. II. Clinical protocol Neuromuscul Disord 12 [Suppl 1]:S45-S48
118. Rando TA, Disatnik MH, Zhou LZ (2000) Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides. Proc Natl Acad Sci USA 97:5363-5368
119. Bartlett RJ, Stockinger S, Denis MM, Bartlett WT, Inverardi L, Le TT, Thi MN, Morris GE, Bogan DJ, Metcalf-Bogan J, Kornegay JN (2000) In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide. Nat Biotechnol 18:615-622
120. Dunckley MG, Manoharan M, Villiet P, Eperon IC, Dickson G (1998) Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides. Hum Mol Genet 7:1083-1090
121. Wilton SD, Lloyd F, Carville K, Fletcher S, Honeyman K, Agrawal S, Kole R (1999) Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides. Neuromuscul Disord 9:330-338
122. Mann CJ, Honeyman K, Cheng AJ, Ly T, Lloyd F, Fletcher S, Morgan JE, Partridge TA, Wilton SD (2001) Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc Natl Acad Sci USA 98:42-47
123. Deutekom JC van, Bremmer-Bout M, Janson AA, Ginjaar IB, Baas F, Den Dunnen JT, van Ommen GJ (2001) Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum Mol Genet 10:1547-1554
124. Lu QL, Mann CJ, Lou F, Bou-Gharios G, Morris GE, Xue SA, Fletcher S, Partridge TA, Wilton SD (2003) Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Nat Med 9:1009-1014
125. Hamilton JW (2001) Gentamicin in pharmacogenetic approach to treatment of cystic fibrosis. Lancet 358:2014-2016
126. Wilschanski M, Famini C, Blau H, Rivlin J, Augarten A, Avital A, Kerem B, Kerem E (2000) A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations. Am J Respir Crit Care Med 161:860-865
127. Barton-Davis ER, Cordier L, Shoturma DI, Leland SE, Sweeney HL (1999) Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 104:375-381
128. Wagner KR, Hamed S, Hadley DW, Gropman AL, Burstein AH, Escolar DM, Hoffman EP, Fischbeck KH (2001) Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. Ann Neurol 49:706-711
129. Dunant P, Walter MC, Karpati G, Lochmuller H (2003) Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle. Muscle Nerve 27:624-627
130. Loveless MO, Kohlhepp SJ, Gilbert DN (1984) The influence of aminoglycoside antibiotics on the in vitro function of rat liver ribosomes. J Lab Clin Med 103:294-303
131. Yoshizawa S, Fourmy D, Puglisi JD (1998) Structural origins of gentamicin antibiotic action. EMBO J 17:6437-6448
132. Gillis JM (1999) Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse. J Muscle Res Cell Motil 20:605-625
133. Fischer MD, Gorospe JR, Felder E, Bogdanovich S, Pedrosa-Domellof F, Ahima RS, Rubinstein NA, Hoffman EP, Khurana TS (2002) Expression profiling reveals metabolic and structural components of extraocular muscles. Physiol Genomics 9:71-84
134. Johnson PL, Bhattacharya SK (1993) Regulation of membrane-mediated chronic muscle degeneration in dystrophic hamsters by calcium-channel blockers: diltiazem, nifedipine and verapamil. J Neurol Sci 115:76-90
135. Badalamente MA, Stracher A (2000) Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition. Muscle Nerve 23:106-111
136. Spencer MJ, Mellgren RL (2002) Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology. Hum Mol Genet 11:2645-2655
137. Arahata K, Engel AG (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 16:193-208
138. Arahata K, Engel AG (1988) Monoclonal antibody analysis of mononuclear cells in myopathies. IV. Cell-mediated cytotoxicity and muscle fiber necrosis. Ann Neurol 23:168-173
139. Barthelmai W (1965) On the effect of corticoid administration on creatine phosphokinase in progressive muscular dystrophy. Verh Dtsch Ges Inn Med 71:624-626
140. Drachman DB, Toyka KV, Myer E (1974) Prednisone in Duchenne muscular dystrophy. Lancet II:1409-1412
141. Griggs RC, Moxley RT III, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP, Cwik VA, Pandya S, Robison J (1993) Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months). Neurology 43:520-527
142. Angelini C, Pegoraro E, Turella E, Intino MT, Pini A, Costa C (1994) Deflazacort in Duchenne dystrophy: study of long-term effect. Muscle Nerve 17:386-391
143. Spencer MJ, Montecino-Rodriguez E, Dorshkind K, Tidball JG (2001) Helper (CD4 (+)) and cytotoxic (CD8 (+)) T cells promote the pathology of dystrophin-deficient muscle. Clin Immunol 98:235-243
144. Granchelli JA, Avosso DL, Hudecki MS, Pollina C (1996) Cromolyn increases strength in exercised mdx mice. Res Commun Mol Pathol Pharmacol 91:287-296
145. Zammit PS, Partridge TA (2002) Sizing up muscular dystrophy. Nat Med 8:1355-1356
146. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL (2002) Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157:137-148
147. Lynch GS, Cuffe SA, Plant DR, Gregorevic P (2001) IGF-I treatment improves the functional properties of fast-and slow-twitch skeletal muscles from dystrophic mice. Neuromuscul Disord 11:260-268
148. McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387:83-90
149. Grobet L, Martin LJ, Poncelet D, Pirottin D, Brouwers B, Riquet J, Schoeberlein A, Dunner S, Menissier F, Massabanda J, Fries R, Hanset R, Georges M (1997) A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 17:71-74
150. Zhu X, Hadhazy M, Wehling M, Tidball JG, McNally EM (2000) Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett 474:71-75
151. Lee SJ, McPherron AC (2001) Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98:9306-9311
152. Yang J, Ratovitski T, Brady JP, Solomon MB, Wells KD, Wall RJ (2001) Expression of myostatin pro domain results in muscular transgenic mice. Mol Reprod Dev 60:351-361
153. Nishi M, Yasue A, Nishimatu S, Nohno T, Yamaoka T, Itakura M, Moriyama K, Ohuchi H, Noji S (2002) A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle. Biochem Biophys Res Commun 293:247-251
154. McPherron AC, Lee SJ (2002) Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109:595-601
155. Thies RS, Chen T, Davies MV, Tomkinson KN, Pearson AA, Shakey QA, Wolfman NM (2001) GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding. Growth Factors 18:251-259
156. Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, Kambadur R (2000) Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275:40235-40243
157. Bengtsson H (2001) Bone morphogenetic protein receptors in the nervous system: neurotrophic functions with emphasis on catecholaminergic neurons. Thesis, Uppsala University
158. Rios R, Carneiro I, Arce VM, Devesa J (2002) Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol 282:C993-C999
159. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, Khurana TS (2002) Functional improvement of dystrophic muscle by myostatin blockade. Nature 420:418-421
160. Wagner KR, McPherron AC, Winik N, Lee SJ (2002) Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol 52:832-836
161. Gramolini AO, Karpati G, Jasmin BJ (1999) Discordant expression of utrophin and its transcript in human and mouse skeletal muscles. J Neuropathol Exp Neurol 58:235-244
162. Chaubourt E, Fossier P, Baux G, Leprince C, Israel M, De La Porte S (1999) Nitric oxide and 1-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy. Neurobiol Dis 6:499-507
163. Blake DJ, Schofield JN, Zuellig RA, Gorecki DC, Phelps SR, Barnard EA, Edwards YH, Davies KE (1995) G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain. Proc Natl Acad Sci USA 92:3697-3701
164. Wilson J, Putt W, Jimenez C, Edwards YH (1999) Up71 and up140, two novel transcripts of utrophin that are homologues of short forms of dystrophin. Hum Mol Genet 8:1271-1278
165. Nguyen TM, Helliwell TR, Simmons C, Winder SJ, Kendrick-Jones J, Davies KE, Morris GE (1995) Full-length and short forms of utrophin, the dystrophin-related protein. FEBS Lett 358:262-266
166. Lumeng CN, Phelps SF, Rafael JA, Cox GA, Hutchinson TL, Begy CR, Adkins E, Wiltshire R, Chamberlain JS (1999) Characterization of dystrophin and utrophin diversity in the mouse. Hum Mol Genet 8:593-599
167. Dennis CL, Tinsley JM, Deconinck AE, Davies KE (1996) Molecular and functional analysis of the utrophin promoter. Nucleic Acids Res 24:1646-1652
168. Burton EA, Tinsley JM, Holzfeind PJ, Rodrigues NR, Davies KE (1999) A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy. Proc Natl Acad Sci USA 96:14025-14030
169. Galvagni F, Oliviero S (2000) Utrophin transcription is activated by an intronic enhancer. J Biol Chem 275:3168-3172
170. Weir AP, Burton EA, Harrod G, Davies KE (2002) A-and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle. J Biol Chem 277:45285-45290
171. Gramolini AO, Angus LM, Schaeffer L, Burton EA, Tinsley JM, Davies KE, Changeux JP, Jasmin BJ (1999) Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein. Proc Natl Acad Sci USA 96:3223-3227
172. Khurana TS, Rosmarin AG, Shang J, Krag TO, Das S, Gammeltoft S (1999) Activation of utrophin promoter by heregulin via the ets-related transcription factor complex GA-binding protein alpha/beta. Mol Biol Cell 10:2075-2086
173. Perkins KJ, Burton EA, Davies KE (2001) The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy. Nucleic Acids Res 29:4843-4850
174. Galvagni F, Capo S, Oliviero S (2001) Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoter. J Mol Biol 306:985-996
175. Gyrd-Hansen M, Krag TO, Rosmarin AG, Khurana TS (2002) Sp1 and the ets-related transcription factor complex GABP alpha/beta functionally cooperate to activate the utrophin promoter. J Neurol Sci 197:27-35
176. Chakkalakal JV, Stocksley MA, Harrison MA, Angus LM, Deschenes-Furry J, St Pierre S, Megeney LA, Chin ER, Michel RN, Jasmin BJ (2003) Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling. Proc Natl Acad Sci USA 100:7791-7796
177. Dubowitz V (2002) Therapeutic possibilities in muscular dystrophy: the hope versus hype. Neuromuscul Disord 12:116